Ingevity (NGVT) Stock | NGVT Stock Price & Analysis

Feed

NGVT

Ingevity NGVT · NYSE

$74.77 +1.44% (+$1.06)

Summary

53 / 100 · Bulios Score

Valuation 27Growth 35Profitability 91Quality 83Debt 17Stability 57

What speaks for it

It earns 12 USD a year on every 100 USD of invested capital.
Out of every 100 USD of revenue, 13 USD is left as free cash.

What to watch

Revenue fell by 11% a year over the last 3 years.
Repaying its net debt would take 5.9 years of operating profit.
The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Is it expensive?

Looks expensive

Bulios Fair Price

Current price $74.77

P/E today 46.9

Chemicals - Specialty industry median

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 46.9 USD for 1 USD of yearly profit.

Valuation in detail

Is it growing?

Slowly

Revenue (USD)

1.4B

1.7B

1.4B

1.2B

1.1B

2021202220232024202520262027

Diluted EPS (USD)

$2.95

$5.50

-$0.15

-$11.85

-$4.61

$5.35

$6.04

2021202220232024202520262027

Analyst estimate

Revenue fell by 0.8% a year over 5 years. Over the last 3 years it fell by 11% a year.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Cost of sales 59 USD
Research and development 2.3 USD
Sales and administration 17 USD
Taxes and other 17 USD
Net profit 4.7 USD

Net profit, industry median (Chemicals - Specialty) 6.0 USD

Out of every 100 USD of revenue, 4.7 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Cash and short-term investments $97.4M

Debt $1.24B

Free cash flow over 12 months $154.9M

Repaying all its debt would take 8.0 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Buy 10
Hold 3
Sell 0

Today's price within the analysts' price targets

Today's price $74.77 Average target $71.5

$56 $83

The average target of $71.5 is 4.4% below today's price. 77% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

Performance Materials 60%
Performance Chemicals 40%

By region

North America 35%
UNITED STATES 31%
Asia Pacific 16%
EMEA 8.3%
CHINA 8.0%
Other 2.4%

Performance Materials brings in 60% of revenue.

Segments in detail